Laboratory News and Research

RSS

People who had COVID-19 are more vulnerable to developing neurological symptoms

Research led by The University of Queensland has found COVID-19 activates the same inflammatory response in the brain as Parkinson's disease.

1 Nov 2022

Researchers use deep neural networks to virtually stain microscopic images of unlabeled tissue

In the hospital, there is a group of doctors who use tissue samples as "evidence materials", analyze the evidence using knives, slicers and microscopes to extract clues from the tissue samples, and provide patients with "verdicts" - diagnostic reports.

31 Oct 2022

Monoclonal antibody shows efficacy in preventing malaria infection in African adults

One dose of an antibody drug safely protected healthy, non-pregnant adults from malaria infection during an intense six-month malaria season in Mali, Africa, a National Institutes of Health clinical trial has found.

31 Oct 2022

Scientists reveal anti-inflammatory molecules that play an important role in aging

Aging involves complicated plot twists and a large cast of characters: inflammation, stress, metabolism changes, and many others. Now, a team of Salk Institute and UC San Diego scientists reveal another factor implicated in the aging process - a class of lipids called SGDGs (3-sulfogalactosyl diacylglycerols) that decline in the brain with age and may have anti-inflammatory effects.

31 Oct 2022

Smartphone code blue notification may accelerate response to in-hospital cardiac arrest

Sixty seconds can make or break the outcome of a hospital "code blue" or cardiac arrest response. New research found a hospital code response team rushing to a patient in cardiac arrest may arrive at least one minute quicker and may also lead to better patient outcomes with the use of a smartphone emergency code notification system that activates the team through text messages.

31 Oct 2022

Favorable outcomes of infants born after maternal COVID-19 during pregnancy

Researchers assess the outcomes of children born to mothers infected during pregnancy with SARS-CoV-2.

30 Oct 2022

Estimating the risk of airborne SARS-CoV-2 transmission in a train carriage

Researchers evaluate the risk of airborne transmission of SARS-CoV-2 in a mechanically ventilated inter-city train carriage.

30 Oct 2022

Study reveals the molecular mechanisms of dynamic activation of DNMT1 by H3Ub2

This study is led by Dr. Na Yang (State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy and Key Laboratory of Medical Data Analysis and Statistical Research of Tianjin, Nankai University), and Dr. Bing Zhu (National Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Science).

28 Oct 2022

Appel Alzheimer's Disease Research Institute Symposium reveals new developments in dementia research

The 10th annual Appel Alzheimer's Disease Research Institute Symposium brought fascinating reports of progress in understanding Alzheimer's and related neurodegenerative diseases.

28 Oct 2022

New insights on antibody response against SARS-CoV-2 Omiron sublineages

Knowing how well vaccination against one SARS-CoV-2 strain (with or without previous infection) counteracts infection with a different strain is a critical research question.

28 Oct 2022

CHG may be the most effective irrigation solution for use during surgical treatment of bone tumors

The widely used disinfectant chlorhexidine gluconate (CHG) appears to be the most effective irrigation solution for use as part of the surgical treatment of bone tumors, suggests an experimental study in The Journal of Bone & Joint Surgery.

28 Oct 2022

'What pediatricians need to know' about monkeypox in children

Children aged 8 years or younger should be considered a group at high risk for more severe monkeypox disease, reports The Pediatric Infectious Disease Journal, the official journal of The European Society for Paediatric Infectious Diseases.

28 Oct 2022

First anti-SARS Cov2 monoclonal antibody candidate of SpikImm demonstrates excellent tolerance

SPK001, the first anti-SARS Cov2 monoclonal antibody candidate of SpikImm, a French biotechnology company founded by Truffle Capital, originally discovered by the Institut Pasteur's Human Immunology Laboratory, directed by Dr. Hugo Mouquet (Inserm Joint Research Unit), has been tested on three initial cohorts of healthy volunteers, and has demonstrated excellent tolerance, in the context of the Phase 1 clinical study, recently labeled as a "national priority" by CAPNET (National Steering Committee for Therapeutic Trials and other Research on Covid-19).

28 Oct 2022

Laboratory News and Research

People who had COVID-19 are more vulnerable to developing neurological symptoms

Researchers use deep neural networks to virtually stain microscopic images of unlabeled tissue

Monoclonal antibody shows efficacy in preventing malaria infection in African adults

Scientists reveal anti-inflammatory molecules that play an important role in aging

Smartphone code blue notification may accelerate response to in-hospital cardiac arrest

Favorable outcomes of infants born after maternal COVID-19 during pregnancy

Estimating the risk of airborne SARS-CoV-2 transmission in a train carriage

Study reveals the molecular mechanisms of dynamic activation of DNMT1 by H3Ub2

Appel Alzheimer's Disease Research Institute Symposium reveals new developments in dementia research

New insights on antibody response against SARS-CoV-2 Omiron sublineages

CHG may be the most effective irrigation solution for use during surgical treatment of bone tumors

'What pediatricians need to know' about monkeypox in children

First anti-SARS Cov2 monoclonal antibody candidate of SpikImm demonstrates excellent tolerance

Research helps to improve the understanding of virtual romance

Research shows in real time how immune memory cells are stored in the bone marrow

Proof-of-principle study: Novel tool advances potential way to deliver gene therapy

Immune checkpoint therapy may be beneficial in certain cases of severe COVID-19

New study pinpoints neurons that slow us down during sickness

Study shows the potential of experimental monoclonal antibodies to treat Epstein-Barr virus infection

Research opens up new avenues for overcoming treatment resistance in colorectal cancer

Viva Saliva Book: The ultimate guide to saliva Book preview Download eBook

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo